Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Onconetix (ONCO) Total Liabilities (2023 - 2025)

Historic Total Liabilities for Onconetix (ONCO) over the last 3 years, with Q3 2025 value amounting to $16.3 million.

  • Onconetix's Total Liabilities fell 2198.32% to $16.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $16.3 million, marking a year-over-year decrease of 2198.32%. This contributed to the annual value of $18.6 million for FY2024, which is 1511.36% down from last year.
  • As of Q3 2025, Onconetix's Total Liabilities stood at $16.3 million, which was down 2198.32% from $12.8 million recorded in Q2 2025.
  • Onconetix's Total Liabilities' 5-year high stood at $25.3 million during Q1 2024, with a 5-year trough of $2.8 million in Q1 2023.
  • Over the past 3 years, Onconetix's median Total Liabilities value was $17.6 million (recorded in 2023), while the average stood at $17.4 million.
  • In the last 5 years, Onconetix's Total Liabilities surged by 80056.45% in 2024 and then crashed by 4671.25% in 2025.
  • Onconetix's Total Liabilities (Quarter) stood at $21.9 million in 2023, then decreased by 15.11% to $18.6 million in 2024, then fell by 12.21% to $16.3 million in 2025.
  • Its Total Liabilities was $16.3 million in Q3 2025, compared to $12.8 million in Q2 2025 and $14.3 million in Q1 2025.